BR112012026361A2 - previsão de terapia e otimização de terapia sanguínea para insuficiência renal, especialmente hemodiálise domiciliar - Google Patents

previsão de terapia e otimização de terapia sanguínea para insuficiência renal, especialmente hemodiálise domiciliar

Info

Publication number
BR112012026361A2
BR112012026361A2 BR112012026361A BR112012026361A BR112012026361A2 BR 112012026361 A2 BR112012026361 A2 BR 112012026361A2 BR 112012026361 A BR112012026361 A BR 112012026361A BR 112012026361 A BR112012026361 A BR 112012026361A BR 112012026361 A2 BR112012026361 A2 BR 112012026361A2
Authority
BR
Brazil
Prior art keywords
therapy
blood
renal failure
prediction
solute
Prior art date
Application number
BR112012026361A
Other languages
English (en)
Inventor
Akonur Alp
Ugur Agar Baris
Kenneth Leypoldt John
Lo Ying-Cheng
Original Assignee
Baxter Healthcare Sa
Baxter Int
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Baxter Healthcare Sa, Baxter Int filed Critical Baxter Healthcare Sa
Publication of BR112012026361A2 publication Critical patent/BR112012026361A2/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M1/00—Suction or pumping devices for medical purposes; Devices for carrying-off, for treatment of, or for carrying-over, body-liquids; Drainage systems
    • A61M1/14—Dialysis systems; Artificial kidneys; Blood oxygenators ; Reciprocating systems for treatment of body fluids, e.g. single needle systems for hemofiltration or pheresis
    • A61M1/16—Dialysis systems; Artificial kidneys; Blood oxygenators ; Reciprocating systems for treatment of body fluids, e.g. single needle systems for hemofiltration or pheresis with membranes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M1/00—Suction or pumping devices for medical purposes; Devices for carrying-off, for treatment of, or for carrying-over, body-liquids; Drainage systems
    • A61M1/14—Dialysis systems; Artificial kidneys; Blood oxygenators ; Reciprocating systems for treatment of body fluids, e.g. single needle systems for hemofiltration or pheresis
    • A61M1/16—Dialysis systems; Artificial kidneys; Blood oxygenators ; Reciprocating systems for treatment of body fluids, e.g. single needle systems for hemofiltration or pheresis with membranes
    • A61M1/1601—Control or regulation
    • A61M1/1613—Profiling or modelling of patient or predicted treatment evolution or outcome
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M1/00—Suction or pumping devices for medical purposes; Devices for carrying-off, for treatment of, or for carrying-over, body-liquids; Drainage systems
    • A61M1/14—Dialysis systems; Artificial kidneys; Blood oxygenators ; Reciprocating systems for treatment of body fluids, e.g. single needle systems for hemofiltration or pheresis
    • A61M1/16—Dialysis systems; Artificial kidneys; Blood oxygenators ; Reciprocating systems for treatment of body fluids, e.g. single needle systems for hemofiltration or pheresis with membranes
    • A61M1/1601—Control or regulation
    • A61M1/1619—Sampled collection of used dialysate, i.e. obviating the need for recovery of whole dialysate quantity for post-dialysis analysis
    • G—PHYSICS
    • G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
    • G16H—HEALTHCARE INFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR THE HANDLING OR PROCESSING OF MEDICAL OR HEALTHCARE DATA
    • G16H20/00—ICT specially adapted for therapies or health-improving plans, e.g. for handling prescriptions, for steering therapy or for monitoring patient compliance
    • G16H20/40—ICT specially adapted for therapies or health-improving plans, e.g. for handling prescriptions, for steering therapy or for monitoring patient compliance relating to mechanical, radiation or invasive therapies, e.g. surgery, laser therapy, dialysis or acupuncture
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M2202/00—Special media to be introduced, removed or treated
    • A61M2202/04—Liquids
    • A61M2202/0496—Urine
    • A61M2202/0498—Urea
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M2205/00—General characteristics of the apparatus
    • A61M2205/15—Detection of leaks
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M2205/00—General characteristics of the apparatus
    • A61M2205/50—General characteristics of the apparatus with microprocessors or computers
    • A61M2205/502—User interfaces, e.g. screens or keyboards
    • A61M2205/505—Touch-screens; Virtual keyboard or keypads; Virtual buttons; Soft keys; Mouse touches
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M2205/00—General characteristics of the apparatus
    • A61M2205/50—General characteristics of the apparatus with microprocessors or computers
    • A61M2205/52—General characteristics of the apparatus with microprocessors or computers with memories providing a history of measured variating parameters of apparatus or patient

Landscapes

  • Health & Medical Sciences (AREA)
  • Urology & Nephrology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Hematology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Anesthesiology (AREA)
  • Vascular Medicine (AREA)
  • Emergency Medicine (AREA)
  • Biomedical Technology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Surgery (AREA)
  • Epidemiology (AREA)
  • Medical Informatics (AREA)
  • Primary Health Care (AREA)
  • External Artificial Organs (AREA)
  • Measuring Pulse, Heart Rate, Blood Pressure Or Blood Flow (AREA)
  • Arrangement Of Elements, Cooling, Sealing, Or The Like Of Lighting Devices (AREA)

Abstract

previsão de terapia e otomização de terapia sanguíncea para insuficiência renal, especialmente hemodiálise domiciliar. trata-se de um sistema de etrapia sanguínea para insuficiência renal que inclui: (i) uma máquina d eterapia sanguínea para insuficiência renal: (ii) uma prescrição de terapia para um paciente pela máquina de terapia sanguínea para insuficiência renal para remover um soluto do sangue do paciente; (iii) um teste que inclui múltiplas amostras de sangue colhidas em múltiplos horários durante uma terapia de teste para determinar os nníveis de concentração do soluto em cada um dos múltiplos horários; e (iv) um dispositivo programado para usar um modelo cinético para o soluto em um primeiro caso com pelo menos um dos níveis de concentração do soluto para estimar pelo menos um parâmetro estimado do paciente. o dispositivo é programado, ainda, para permitir que um usuário determine pelo menos uma entre a duração de terapia, a frequência de terapia, a taxa de vaxão de dialisato ou a taxa de vazão de sangue para a prescrição de terapia.
BR112012026361A 2010-04-16 2011-04-15 previsão de terapia e otimização de terapia sanguínea para insuficiência renal, especialmente hemodiálise domiciliar BR112012026361A2 (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US32511310P 2010-04-16 2010-04-16
PCT/US2011/032736 WO2011130669A1 (en) 2010-04-16 2011-04-15 Therapy prediction and optimization for renal failure blood therapy, especially home hemodialysis

Publications (1)

Publication Number Publication Date
BR112012026361A2 true BR112012026361A2 (pt) 2019-09-24

Family

ID=44041518

Family Applications (1)

Application Number Title Priority Date Filing Date
BR112012026361A BR112012026361A2 (pt) 2010-04-16 2011-04-15 previsão de terapia e otimização de terapia sanguínea para insuficiência renal, especialmente hemodiálise domiciliar

Country Status (10)

Country Link
EP (3) EP2558967B1 (pt)
JP (8) JP5747072B2 (pt)
AU (2) AU2011239489B2 (pt)
BR (1) BR112012026361A2 (pt)
CA (2) CA2796496C (pt)
CO (3) CO6660434A2 (pt)
ES (2) ES2501715T3 (pt)
MX (4) MX347513B (pt)
NZ (2) NZ602996A (pt)
WO (2) WO2011130669A1 (pt)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US9132219B2 (en) 2010-04-16 2015-09-15 Baxter International Inc. Therapy prediction and optimization of serum potassium for renal failure blood therapy, especially home hemodialysis
US8845570B2 (en) 2010-04-16 2014-09-30 Baxter International Inc. Therapy prediction and optimization for renal failure blood therapy, especially home hemodialysis
MX361881B (es) * 2013-08-16 2018-12-18 Baxter Int Prediccion y optimizacion de terapia de potasio en suero para terapia de sangre para insuficiencia renal, especialmente hemodialisis domiciliaria.
DE102014005122A1 (de) * 2014-04-08 2015-10-08 Fresenius Medical Care Deutschland Gmbh Verfahren zur Abschätzung der Behandlungsdauer einer Pertionealdialyse-Behandlung
EP3204064B1 (en) 2014-10-10 2020-12-02 NxStage Medical, Inc. Flow balancing devices, methods, and systems
JP7086926B2 (ja) 2016-07-18 2022-06-20 ネクステージ メディカル インコーポレイテッド フローバランシングの装置、方法、及びシステム
EP3506962B1 (en) 2016-08-30 2023-11-22 NxStage Medical, Inc. Parameter monitoring in medical treatment systems
JP2019212249A (ja) * 2018-06-10 2019-12-12 大 益満 プログラム及び情報処理システム
CN115050238B (zh) * 2022-07-08 2024-03-12 卡斯柯信号有限公司 一种基于真实ctc系统的多模式切换仿真实训系统

Family Cites Families (26)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5602116A (en) * 1988-08-02 1997-02-11 Bone Care International, Inc. Method for treating and preventing secondary hyperparathyroidism
US5230702A (en) * 1991-01-16 1993-07-27 Paradigm Biotechnologies Partnership Hemodialysis method
DE69324471T2 (de) * 1992-10-13 1999-12-23 Baxter International Inc., Deerfield Fluessigkeitsentnahmemodul
JP2812460B2 (ja) * 1995-10-04 1998-10-22 日機装株式会社 血液浄化モニタ装置
JP3402360B2 (ja) * 1998-08-21 2003-05-06 株式会社ジェイ・エム・エス 腹膜透析システム
AUPP790898A0 (en) * 1998-12-23 1999-01-28 Life Therapeutics Limited Renal dialysis
EP1396274B2 (en) * 2002-09-05 2013-05-22 Gambro Lundia AB Controller for a blood treatment equipment
US20040048837A1 (en) * 2002-09-06 2004-03-11 Lazarus J. Michael Method for treatment of renal disease
JP4379027B2 (ja) * 2003-05-14 2009-12-09 株式会社ジェイ・エム・エス 腹膜透析および血液透析併用プランニング方法ならびに腹膜透析および血液透析併用プランニング装置
ES2344512T3 (es) * 2005-06-09 2010-08-30 Gambro Lundia Ab Aparato medico y metodo para configurar un aparato medico.
US8273049B2 (en) 2007-02-27 2012-09-25 Deka Products Limited Partnership Pumping cassette
DE102006045437A1 (de) * 2006-09-26 2008-04-03 Fresenius Medical Care Deutschland Gmbh Vorrichtung und Verfahren zur Vorgabe einer Dialysierflüssigkeitsrate oder Blutflussrate für eine extrakorporale Blutbehandlung
US8562834B2 (en) 2007-02-27 2013-10-22 Deka Products Limited Partnership Modular assembly for a portable hemodialysis system
US20090107335A1 (en) 2007-02-27 2009-04-30 Deka Products Limited Partnership Air trap for a medical infusion device
US8042563B2 (en) 2007-02-27 2011-10-25 Deka Products Limited Partnership Cassette system integrated apparatus
US9028691B2 (en) 2007-02-27 2015-05-12 Deka Products Limited Partnership Blood circuit assembly for a hemodialysis system
US8409441B2 (en) * 2007-02-27 2013-04-02 Deka Products Limited Partnership Blood treatment systems and methods
US8393690B2 (en) 2007-02-27 2013-03-12 Deka Products Limited Partnership Enclosure for a portable hemodialysis system
CN101772783A (zh) * 2007-08-03 2010-07-07 皇家飞利浦电子股份有限公司 药物动力学建模的方法、装置、计算机可读介质及用途
US7981281B2 (en) 2008-07-09 2011-07-19 Baxter International, Inc. Dialysis system having regimen generation methodology
US8062513B2 (en) 2008-07-09 2011-11-22 Baxter International Inc. Dialysis system and machine having therapy prescription recall
US9514283B2 (en) 2008-07-09 2016-12-06 Baxter International Inc. Dialysis system having inventory management including online dextrose mixing
US8168063B2 (en) * 2008-07-09 2012-05-01 Baxter International Inc. Dialysis system having filtering method for determining therapy prescriptions
US8057679B2 (en) 2008-07-09 2011-11-15 Baxter International Inc. Dialysis system having trending and alert generation
EP2163272B1 (en) * 2008-09-15 2014-06-25 B. Braun Avitum AG Device to early predict the Kt/V parameter in kidney substitution treatments
US8999169B2 (en) * 2008-10-17 2015-04-07 Fresenius Medical Care Holdings, Inc. Method of determining a phosphorus binder dosage for a dialysis patient

Also Published As

Publication number Publication date
CA2796496C (en) 2018-03-20
CO6620023A2 (es) 2013-02-15
ES2802609T3 (es) 2021-01-20
MX347513B (es) 2017-04-28
CO6630153A2 (es) 2013-03-01
JP2022095842A (ja) 2022-06-28
JP7057321B2 (ja) 2022-04-19
AU2011239488B2 (en) 2015-05-21
JP7438257B2 (ja) 2024-02-26
CA2796505A1 (en) 2011-10-20
JP5747072B2 (ja) 2015-07-08
EP2558966A1 (en) 2013-02-20
JP2013524892A (ja) 2013-06-20
EP2558967B1 (en) 2020-04-15
JP6078582B2 (ja) 2017-02-08
JP6543279B2 (ja) 2019-07-10
AU2011239489B2 (en) 2015-04-02
MX2022001536A (es) 2022-05-26
EP2558967A1 (en) 2013-02-20
CA2796505C (en) 2018-12-11
JP6018567B2 (ja) 2016-11-02
NZ603010A (en) 2014-05-30
JP2015165914A (ja) 2015-09-24
AU2011239488A1 (en) 2012-11-08
WO2011130669A1 (en) 2011-10-20
CO6660434A2 (es) 2013-04-30
MX2012012062A (es) 2013-06-28
JP2019188179A (ja) 2019-10-31
JP2015221383A (ja) 2015-12-10
JP6043850B2 (ja) 2016-12-14
AU2011239489A1 (en) 2012-11-08
CA2796496A1 (en) 2011-10-20
JP2013524893A (ja) 2013-06-20
EP3706134A1 (en) 2020-09-09
ES2501715T3 (es) 2014-10-02
WO2011130668A1 (en) 2011-10-20
MX2012012061A (es) 2013-06-28
EP2558966B1 (en) 2014-07-16
JP2024045513A (ja) 2024-04-02
JP2017094150A (ja) 2017-06-01
NZ602996A (en) 2015-02-27

Similar Documents

Publication Publication Date Title
BR112012026361A2 (pt) previsão de terapia e otimização de terapia sanguínea para insuficiência renal, especialmente hemodiálise domiciliar
BR112013026319A2 (pt) método e aparelho para o monitoramento de um tratamento de um paciente, preferivelmente para o monitoramento da hemodiálise, hemodiafiltração e/ou diálise peritoneal
EA201492106A1 (ru) Способ и устройство для контроля экстракорпоральной обработки крови пациента
BR112014004870A2 (pt) controle de fluxo de dialisado
EA201591789A1 (ru) Ингаляционное устройство, способ управления и компьютерная программа
MY175997A (en) Antl-adrenomedullin (adm) antibody or anti-adm antibody fragment or anti-adm non-ig protein scaffold for reducing the risk of mortality in a patient having a chronic or acute disease or acute condition
BR112015022195A2 (pt) sistema e método para trocas por diálise peritoneal que têm unidade energizante reutilizável
BR112012023243A2 (pt) sistema para realizar um tratamento de sangue.
WO2013101292A3 (en) Fluid volume monitoring for patients with renal disease
BR112013000745A2 (pt) "método para diagnosticar ou detectar câncer colorretal em um individuo, método de tratamento e método para monitorar a eficacia de tratamento de câncer colorretal em um indivíduo"
BR112014002682A8 (pt) método
BR112012031252A2 (pt) aparelho para tratamento extracorpóreo de sangue
MX2012008144A (es) Sistema y metodo para monitoreo de por lo menos un parametro sanguineo.
TR201820019T4 (tr) Metilglioksal hidroimidazolonun (MGH1) belirlenmesi aracılığıyla diyabet yönetiminin geliştirilmesine yönelik yöntem ve kit.
BR112013019563A2 (pt) métodos para prognóstico de ferida, para tratamento de ferida, para prognosticar se um paciente pode ser responsivo ao tratamento de uma ferida que exsuda um fluido de ferida, e para tratar uma ferida que exsuda um fluido de ferida, dispositivo para medir simultaneamente ou sequencialmente os níveis de hne e de pelo menos uma mmp em uma amostra de fluido de ferida, aparelho para diagnóstico, e, estojo.
BR112014010067A2 (pt) método e sistema para usar disparos de rastreador para estimar volumes de influxo de fluidos a partir de diferentes zonas de influxo para um fluxo de produção em um poço
ZA201403549B (en) Anti-adrenomedullin (adm) antibody or anti-adm antibody fragment or anti-adm non-ig scaffold for use in therapy of an acute disease or acute condition of a patient for stabilizing the circulation
SG10201600502XA (en) Methods and kits for predicting the risk of respiratory failure, renal failure or thrombopenia in a septic patient by measuring endocan levels in blood
MD3593808T2 (ro) Polimeri de legare a protonilor pentru administrare orală
BR112015030526A2 (pt) detecção de aorta automatizada em um volume de tca
ATE420678T1 (de) Dialysemaschine mit einer einrichtung zur bestimmung der dialysedosis
BR112018070811A2 (pt) método para fornecer retroinformação, sistema para fornecer retroinformação
BR112013007046A2 (pt) método para a otimização do consumo de dialisato em uma unidade de tratamento sanguíneo e aparato para o tratamento sanguíneo
ES2571111T3 (es) Método de diagnóstico para predicción de la respuesta de un paciente a la quimioviroterapia o radioviroterapia
MX2019005684A (es) Métodos para detectar mutaciones de fibrosis quística mediante el uso de extracción con puntas mitra.

Legal Events

Date Code Title Description
B08F Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette]
B08K Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette]

Free format text: EM VIRTUDE DO ARQUIVAMENTO PUBLICADO NA RPI 2543 DE 01-10-2019 E CONSIDERANDO AUSENCIA DE MANIFESTACAO DENTRO DOS PRAZOS LEGAIS, INFORMO QUE CABE SER MANTIDO O ARQUIVAMENTO DO PEDIDO DE PATENTE, CONFORME O DISPOSTO NO ARTIGO 12, DA RESOLUCAO 113/2013.